Safety and Immunogenicity of Recombinant Hepatitis B Vaccines in the Neonates

NCT02764671 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

5000

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis
Hepatitis B
Liver Diseases
Digestive System Diseases

Interventions

BIOLOGICAL: 10μg/0.5ml recombinant hepatitis B vaccine

Sponsor

Shenzhen Kangtai Biological Products Co., LTD

Collaborators

[object Object]